PREVYMIS 20 mg/1
LETERMOVIR · PELLET · Merck Sharp & Dohme LLC
Prevymis (letermovir) is an oral medication used to prevent cytomegalovirus infection in certain patients who have received a stem cell or bone marrow transplant. It works by inhibiting a viral enzyme needed for the virus to replicate.
Key Facts
- Brand Name
- PREVYMIS
- Generic Name
- LETERMOVIR
- NDC Code (Product)
0006-5086- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 20 mg/1
- Dosage Form
- PELLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA219104
- Drug Class
- Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]
- Marketing Start
- 08/30/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is PREVYMIS used for?
Prevymis (letermovir) is an oral medication used to prevent cytomegalovirus infection in certain patients who have received a stem cell or bone marrow transplant. It works by inhibiting a viral enzyme needed for the virus to replicate.
Is PREVYMIS a controlled substance?
PREVYMIS is not classified as a controlled substance by the DEA.
What is the generic name for PREVYMIS?
The generic name for PREVYMIS is LETERMOVIR. There are no other listed brand versions of LETERMOVIR.
What is the NDC code for PREVYMIS 20 mg/1?
The NDC (National Drug Code) for PREVYMIS 20 mg/1 is 0006-5086, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)